S. 2554

PCMA supports legislation for lowest prices for prescription drugs

July 24, 2018 by Chain Drug Review Mark Merritt, Pharmaceutical Care Management Association (PCMA), S. 2554, the Patient Right to Know Drug Prices Act Leading Headlines, Pharmacy

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement on S. 2554, the Patient Right to Know Drug Prices Act, scheduled to be marked up tomorrow in the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP): “PCMA strongly supports S. 2554, legislation that will ensure America’s

Senators aim to quash pharmacy gag clauses

March 16, 2018 by Chain Drug Review American Pharmacists Association, B. Douglas Hoey, Claire McCaskill, CVS Health, Debbie Stabenow, Know the Lowest Price Act, National Community Pharmacists Association, Patient Right to Know Drug Prices Act, Pharmaceutical Care Management Association, pharmacy gag clauses, prescription drug pricing transparency, S. 2553, S. 2554, Susan Collins, Tom Menighan Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — A group of senators are sponsoring legislation to bring more prescription drug pricing transparency to the pharmacy counter. Sens. Susan Collins (R., Maine), Claire McCaskill (D., Mo.) and Debbie Stabenow (D., Mich.) yesterday introduced the Patient Right to Know Drug Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553), which would